Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction

Details for Australian Patent Application No. 2008316794 (hide)

Owner Revalesio Corporation

Inventors Wood, Anthony B.; Watson, Richard L.; Archambeau, Gregory J.

Agent Davies Collison Cave

Pub. Number AU-A-2008316794

PCT Pub. Number WO2009/055614

Priority 61/048,347 28.04.08 US; PCT/ US2007/082580 25.10.07 US; 61/048,404 28.04.08 US; 60/982,719 25.10.07 US; 60/982,720 25.10.07 US; 61/048,340 28.04.08 US; 61/048,332 28.04.08 US; PCT/ US2007/082578 25.10.07 US; PCT/ US2007/082581 25.10.07 US

Filing date 23 October 2008

Wipo publication date 30 April 2009

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/055614 Priority application(s): WO2009/055614

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008316796-Genetic incorporation of 3-aminotyrosine into reductases

2008316793-Inhibition of urokinase-type plasminogen activator (uPA) activity